IDH1 and neoplasm: Analysis of the recurrence revealed an analogous molecular profile: The tumor showed an IDH1 R132H mutation (Fig. 3g) with IDH2 wildtype (Fig. 3h) and TERT C250T promoter mutation (Fig. 3i).